Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Mayzent for secondary progressive MS

Jan. 21, 2020

FDA approves Polaryx's IND for PLX-200 in LINCL

Jan. 21, 2020

Sunosi approved in E.U. for excessive daytime sleepiness in adults with narcolepsy or OSA

Jan. 21, 2020

FDA clears Bridge Biotherapeutics' IND for BBT-176

Jan. 21, 2020

Oncolytic viruses increase sensitivity to checkpoint blockade

Jan. 21, 2020

TSRL discloses various compounds for viral infections

Jan. 21, 2020

Hepatikos Therapeutics describes new MAP3K5 inhibitors

Jan. 21, 2020

Tufts Medical Center divulges CDK6 inhibitors

Jan. 21, 2020

Pliant Therapeutics patents integrin alphavbeta6 antagonists

Jan. 21, 2020

Proteostasis Therapeutics synthesizes new USP14 inhibitors

Jan. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...